//AstraZeneca says vaccine trial analysis shows 76 percent efficacy

AstraZeneca says vaccine trial analysis shows 76 percent efficacy

The company had faced questions about outdated information but said Wednesday that the analysis of a U.S. trial confirms it is safe and effective.